Related Experiment Videos
Cerebroprotective effect of flunarizine
R Nikolov1, M Nikolova, M Dikova
1Chemical Pharmaceutical Research Institute, Sofia, Bulgaria.
Summary
Flunarizine demonstrated significant cerebroprotective effects across various hypoxia and ischemia models in animals. This drug enhanced survival times and cortical resistance, outperforming several reference medications.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Cerebrovascular diseases pose significant health challenges.
- Identifying effective neuroprotective agents is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the cerebroprotective efficacy of flunarizine.
- To compare flunarizine's effects against established reference drugs.
Main Methods:
- Animal models of hypobaric hypoxia, complete ischemia, anoxic hypoxia, hemic hypoxia, incomplete ischemia, and asphyxic hypoxia were utilized.
- Flunarizine's effects on survival time and cortical resistance were assessed.
- Electroencephalogram (EEG) analysis was performed during asphyxic hypoxia.
Main Results:
- Flunarizine significantly increased survival time in all tested hypoxia and ischemia models.
- The neuroprotective effect was most pronounced in complete ischemia, exceeding that of reference drugs.
- Flunarizine enhanced cortical resistance and accelerated recovery post-asphyxic hypoxia, with EEG changes indicating a protective action.
Conclusions:
- Flunarizine exhibits potent cerebroprotective properties.
- Its efficacy in mitigating hypoxic and ischemic brain injury is superior to several comparator drugs.
- Flunarizine represents a promising therapeutic agent for conditions involving cerebral ischemia and hypoxia.